Market Place
Sourcing Support
ProBioGen, ImmunOs Therapeutics Extend Clinical Mfg. Pact
13 Apr 2023 //
CONTRACT PHARMA
ProBioGen & ImmunOs join hands to deliver innovative therapy for cancer patients
13 Apr 2023 //
INDIAN PHARMA POST
ImmunOs Therapeutics gets TGA approval to begin first-in-human trial of IOS-1002
19 Jan 2023 //
PHARMABIZ
ImmunOs Therapeutics Announces Appointment of Joseph Leveque, MD
05 Oct 2022 //
PHARMIWEB
A former Merck director`s Pfizer-backed biotech in nascent LILRB field
07 Jun 2022 //
ENDPTS
ImmunOs Therapeutics´ Lead Program Shows Strong Anti-Tumor Activity
15 Nov 2021 //
GLOBENEWSWIRE
ImmunOs Therapeutics gets public funding from Eurostars and Innosuisse for novel
14 Apr 2021 //
PHARMBIZ
ImmunOs Therapeutics gets public funding from Eurostars and Innosuisse
13 Apr 2021 //
PHARMBIZ
ImmunOs Uses ProBioGen’s Pathway Modulator Technology
27 Oct 2020 //
CONTRACT PHARMA
ImmunOs Uses ProBioGen’s Pathway Modulator Technology
26 Oct 2020 //
CONTRACTPHARMA
ImmunOs has pipeline of novel agents in development
25 Feb 2020 //
BIOSPECTRUMASIA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.